FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Glendenning

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Paul Glendenning; R L Prince
What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?
Paul Glendenning; Charles A Inderjeeth
Vitamin D: methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment.
Paul Glendenning; Charles A Inderjeeth
Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Glendenning (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Paul Glendenning; R L Prince
What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?
Internal medicine journal 2012;42(10):1069-72.
2012: Paul Glendenning; Charles A Inderjeeth
Vitamin D: methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment.
Clinical biochemistry 2012;45(12):901-6.
2012: Paul Glendenning; Charles A Inderjeeth
Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment.
Pathology 2012;44(2):160-5.
2012: Paul Glendenning; Peter Howat; Charles Inderjeeth; Joshua R Lewis; Kun Zhu; Richard L Prince
Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(1):170-6.
2011: Michael W Clarke; Brian Cooke; Kirsten Hoad; Paul Glendenning
Improved plasma free metadrenaline analysis requires mixed mode cation exchange solid-phase extraction prior to liquid chromatography tandem mass spectrometry detection.
Annals of clinical biochemistry 2011;48(Pt 4):352-7.
2011: Paul Glendenning
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards: osteoporos int 2011;22:391-420.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2011;32(1):45-7.
2010: Neil Boudville; C Inderjeeth; G J Elder; Paul Glendenning
Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure.
Clinical endocrinology 2010;73(3):299-304.
2010: Jonathan M Grasko; Hieu H Nguyen; Paul Glendenning
Delayed diagnosis of primary hyperaldosteronism.
BMJ (Clinical research ed.) 2010;340():c2461.
2009: Paul Glendenning; Gerard T Chew; Hannah M Seymour; Melissa J Gillett; Peter Goldswain; Charles A Inderjeeth; Samuel D Vasikaran; Mario Taranto; Alexander A Musk; William D Fraser
Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
Bone 2009;45(5):870-5.
2009: Paul Glendenning; Deepani Siriwardhana; Kirsten Hoad; Alexander Musk
Thyroxine autoantibody interference is an uncommon cause of inappropriate TSH secretion using the Immulite 2000 assay.
Clinica chimica acta; international journal of clinical chemistry 2009;403(1-2):136-8.
2009: Charles A Inderjeeth; Adrian C H Foo; Michelle Mei Yee Lai; Paul Glendenning
Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
Bone 2009;44(5):744-51.
2008: Paul Glendenning
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2008;29(2):83-5.
2008: Suzanna E L Temple; Kym Pham; Paul Glendenning; Michael Phillips; Grant W Waterer
Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4.
Cellular immunology 2008;251(2):69-71.
2006: Samuel D Vasikaran; Paul Glendenning; Howard A Morris
The role of biochemical markers of bone turnover in osteoporosis management in clinical practice.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2006;27(3):119-21.
2006: Paul Glendenning; Mario Taranto; Jane M Noble; Alexander A Musk; C Hammond; Peter Goldswain; W D Fraser; Samuel D Vasikaran
Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays.
Annals of clinical biochemistry 2006;43(Pt 1):23-30.
2005: Hannah M Seymour; Paul Glendenning
Fit for a fracture.
The Medical journal of Australia 2005;183(4):213-4.
2004: Richard L Prince; Paul Glendenning
8: Disorders of bone and mineral other than osteoporosis.
The Medical journal of Australia 2004;180(7):354-9.
2003: Ian M Dick; Jie Liu; Paul Glendenning; Richard L Prince
Estrogen and androgen regulation of plasma membrane calcium pump activity in immortalized distal tubule kidney cells.
Molecular and cellular endocrinology 2003;212(1-2):11-8.
2003: Paul Glendenning
Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines.
Internal medicine journal 2003;33(12):598-603.
2003: Paul Glendenning; Jane M Noble; Mario Taranto; Alexander A Musk; Marjory McGuiness; Peter Goldswain; William D Fraser; Samuel D Vasikaran
Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases.
Annals of clinical biochemistry 2003;40(Pt 5):546-51.
2002: Jane M Noble; Marjory McGuiness; Paul Glendenning
Low rate of compliance with ergocalciferol therapy in vitamin-D-deficient patients with hip fracture.
The Medical journal of Australia 2002;177(5):280.
2002: Paul Glendenning; Samuel D Vasikaran
Surgically correctable hypertension.
Pathology 2002;34(3):297-8.
2002: Paul Glendenning; Bronwyn G A Stuckey
The estimated prevalence of familial hypocalciuric hypercalcemia (FHH).
Calcified tissue international 2002;70(6):512; author reply 512-3.
2002: Paul Glendenning; Leonie L A Laffer; Hayley K Weber; Alexander A Musk; Samuel D Vasikaran
Parathyroid hormone is more stable in EDTA plasma than in serum.
Clinical chemistry 2002;48(5):766-7.
2002: Paul Glendenning; Alexander A Musk; Mario Taranto; Samuel D Vasikaran
Preanalytical factors in the measurement of intact parathyroid hormone with the DPC IMMULITE assay.
Clinical chemistry 2002;48(3):566-7.
2002: Paul Glendenning; Samuel D Vasikaran
Vitamin D status and redefining serum PTH reference range in the elderly.
The Journal of clinical endocrinology and metabolism 2002;87(2):946-7.
2002: Paul Glendenning; Samuel D Vasikaran
Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Internal medicine journal 2002;32(1-2):56-8.
2001: Paul Glendenning; Thomas Ratajczak; Ian M Dick; Richard L Prince
Regulation of the 1b isoform of the plasma membrane calcium pump by 1,25-dihydroxyvitamin D3 in rat osteoblast-like cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(3):525-34.
2000: Paul Glendenning; P T Pullan; Neville W Knuckey
Pituitary apoplexy: the importance of citing the differential diagnosis.
The Medical journal of Australia 2000;173(10):548-9.
2000: Paul Glendenning; Thomas Ratajczak; Richard L Prince; Nandor Garamszegi; Emanuel E Strehler
The promoter region of the human PMCA1 gene mediates transcriptional downregulation by 1,25-dihydroxyvitamin D(3).
Biochemical and biophysical research communications 2000;277(3):722-8.
2000: Paul Glendenning; Thomas Ratajczak; Ian M Dick; Richard L Prince
Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cells.
Archives of biochemistry and biophysics 2000;380(1):126-32.
2000: Paul Glendenning; DH Gutteridge; Robert W Retallack
Treatment of primary hyperparathyroidism.
The New England journal of medicine 2000;342(13):976; author reply 976-7.
1999: Paul Glendenning; G N Kent; B D Adler; LR Matz; I Watson; G J O'Driscoll; David M Hurley
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
Clinical endocrinology 1999;50(3):347-55.
1998: Paul Glendenning; DH Gutteridge; Robert W Retallack; Bronwyn G A Stuckey; D G Kermode; GN Kent
High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria.
Australian and New Zealand journal of medicine 1998;28(2):173-8.
1996: Paul Glendenning; P T Pullan; D Gulland; A J Edis
Surgically proven primary hyperparathyroidism with a suppressed intact parathyroid hormone.
The Medical journal of Australia 1996;165(4):197-8.